{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:17:45Z","timestamp":1794914265883,"version":"4.9.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Neuromuscular blocking agents (NMBAs) show potential benefits on mortality and other complications of acute respiratory distress syndrome (ARDS) in adult patients. Evidence-based decisions and processes ensure appropriate use of neuromuscular blockade in adult patients with ARDS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The objective of these guidelines was to develop evidence-based recommendations for the administration of NMBAs in critically ill adult patients with ARDS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>The American College of Critical Care Medicine Board convened a 21-member multidisciplinary panel of experts in critical care medicine, nursing, respiratory therapy, pharmacology, surgery, neurology, and anesthesiology. The panel included two expert methodologists specialized in developing evidence-based recommendations in alignment with the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. Conflict-of-interest policies were strictly followed during all phases of guidelines development including task force selection and voting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The panel members identified and formulated five Population, Intervention, Comparison, and Outcome questions. We conducted a systematic review for each question to identify the best available evidence, statistically analyzed the evidence, and assessed the certainty of the evidence using the GRADE methodology. We used the GRADE evidence-to-decision framework to formulate the recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The panel generated two conditional recommendations. One recommendation is to use NMBAs in adults with ARDS with Pa\n                      <jats:sc>o<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      \/F\n                      <jats:sc>io<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      less than 150. For the other recommendations, there was equipoise in the recommendation for and against using titratable vs. fixed-dose NMBA dosing, a monitoring-based strategy for assessing depth of sedation and analgesia in adults with ARDS before initiating or while receiving neuromuscular blockade, and administration of NMBAs for patients who are proned, due to overall lack of evidence in critically ill patients and due to considerations of patient safety and experience concerns.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These guidelines provide additional perspectives on the use of NMBA in patients with ARDS, recognizing that institutional and patient-specific considerations must help to guide the decision-making process.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000007002","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:20:15Z","timestamp":1772551215000},"page":"634-643","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome"],"prefix":"10.1097","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8909-9921","authenticated-orcid":false,"given":"Brian L.","family":"Erstad","sequence":"first","affiliation":[{"name":"University of Arizona, R. Ken Coit College of Pharmacy, Tucson, AZ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Cobas","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine, Miami, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Qadir","sequence":"additional","affiliation":[{"name":"University of California\u2014Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez","family":"Alshamsi","sequence":"additional","affiliation":[{"name":"College of Medicine and Health Sciences, United Arab Emirates University, United Arab Emirates."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Sharif","sequence":"additional","affiliation":[{"name":"McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Devine","sequence":"additional","affiliation":[{"name":"Diocese of Scranton, Scranton, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Devine","sequence":"additional","affiliation":[{"name":"Geisinger Medical Center, Danville, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Einav","sequence":"additional","affiliation":[{"name":"Maccabbi Health Services and Hebrew University Faculty of Medicine, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Elmer","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Fort","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine, Miami, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Harrod","sequence":"additional","affiliation":[{"name":"Society for Critical Care Medicine, Mount Prospect, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojdeh S.","family":"Heavner","sequence":"additional","affiliation":[{"name":"University of Maryland School of Pharmacy, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D.","family":"Lamb","sequence":"additional","affiliation":[{"name":"Sentara\u2014Martha Jefferson Hospital, Charlottesville, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Mehta","sequence":"additional","affiliation":[{"name":"Sinai Health System and University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dannette A.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"ChristianaCare, Wilmington, DE."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathima","family":"Paruk","sequence":"additional","affiliation":[{"name":"University of Pretoria, Pretoria, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Piraino","sequence":"additional","affiliation":[{"name":"McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Sacha","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildy M.","family":"Schell-Chaple","sequence":"additional","affiliation":[{"name":"University of California\u2014San Francisco School of Nursing, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmili","family":"Sinha","sequence":"additional","affiliation":[{"name":"Apollo Hospitals, Bhubaneswar, Odisha, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Smith","sequence":"additional","affiliation":[{"name":"University of Georgia College of Pharmacy, Athens, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Topeli","sequence":"additional","affiliation":[{"name":"Hacettepe University, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Sarwal","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University School of Medicine, Richmond, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"R1-20260430","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/00003246-199509000-00022","article-title":"Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: An executive summary. Society of Critical Care Medicine.","volume":"23","author":"Shapiro","year":"1995","journal-title":"Crit Care Med"},{"key":"R2-20260430","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00003246-200201000-00021","article-title":"Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient.","volume":"30","author":"Murray","year":"2002","journal-title":"Crit Care Med"},{"key":"R3-20260430","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/CCM.0000000000002027","article-title":"Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient.","volume":"44","author":"Murray","year":"2016","journal-title":"Crit Care Med"},{"key":"R4-20260430","doi-asserted-by":"crossref","first-page":"3000605221128148","DOI":"10.1177\/03000605221128148","article-title":"Neuromuscular blocking agents in the intensive care unit.","volume":"50","author":"Rodriguez-Blanco","year":"2022","journal-title":"J Int Med Res"},{"key":"R10-20260430","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1097\/01.CCM.0000239435.87433.0D","article-title":"Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome.","volume":"34","author":"Forel","year":"2006","journal-title":"Crit Care Med"},{"key":"R11-20260430","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.CCM.0000104114.72614.BC","article-title":"Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome.","volume":"32","author":"Gainnier","year":"2004","journal-title":"Crit Care Med"},{"key":"R12-20260430","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00134-016-4653-4","article-title":"Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.","volume":"43","author":"Guervilly","year":"2017","journal-title":"Intensive Care Med"},{"key":"R13-20260430","first-page":"325","article-title":"Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome.","volume":"26","author":"Lyu","year":"2014","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"R14-20260430","first-page":"787","article-title":"Early neuromuscular blockade in the acute respiratory distress syndrome. Reply.","volume":"381","author":"Moss","year":"2019","journal-title":"N Engl J Med"},{"key":"R15-20260430","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJMoa1005372","article-title":"Neuromuscular blockers in early acute respiratory distress syndrome.","volume":"363","author":"Papazian","year":"2010","journal-title":"N Engl J Med"},{"key":"R16-20260430","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/cbdd.12711","article-title":"Steroidal ammonium compounds as new neuromuscular blocking agents.","volume":"87","author":"Rao","year":"2016","journal-title":"Chem Biol Drug Des"},{"key":"R17-20260430","doi-asserted-by":"crossref","first-page":"154165","DOI":"10.1016\/j.jcrc.2022.154165","article-title":"Physicians\u2019 attitudes and perceptions of neuromuscular blocker infusions in ARDS.","volume":"72","author":"Train","year":"2022","journal-title":"J Crit Care"},{"key":"R18-20260430","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jcrc.2021.05.011","article-title":"Comparison of fixed dose versus train-of-four titration of cisatracurium in acute respiratory distress syndrome.","volume":"65","author":"Thompson Bastin","year":"2021","journal-title":"J Crit Care"},{"key":"R19-20260430","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13613-017-0305-2","article-title":"How to reduce cisatracurium consumption in ARDS patients: The TOF-ARDS study.","volume":"7","author":"Hraiech","year":"2017","journal-title":"Ann Intensive Care"},{"key":"R20-20260430","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00540-008-0613-7","article-title":"Different recovery of the train-of-four ratio from rocuronium-induced neuromuscular blockade in the diaphragm and the tibialis anterior muscle in rat.","volume":"22","author":"Osawa","year":"2008","journal-title":"J Anesth"},{"key":"R21-20260430","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bjae.2023.10.005","article-title":"Neuromuscular block management: Evidence-based principles and practice.","volume":"24","author":"Rodney","year":"2024","journal-title":"BJA Educ"},{"issue":"9 Suppl 1","key":"R22-20260430","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/CCM.0b013e3182a16879","article-title":"Psychometric analysis of subjective sedation scales in critically ill adults.","volume":"41","author":"Robinson","year":"2013","journal-title":"Crit Care Med"},{"key":"R23-20260430","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12028-022-01565-5","article-title":"Processed electroencephalogram-based monitoring to guide sedation in critically ill adult patients: Recommendations from an international expert panel-based consensus.","volume":"38","author":"Rasulo","year":"2023","journal-title":"Neurocrit Care"},{"key":"R24-20260430","doi-asserted-by":"crossref","first-page":"109818","DOI":"10.1016\/j.jclinane.2020.109818","article-title":"Incidence of residual neuromuscular blockade and use of neuromuscular blocking agents with or without antagonists: A systematic review and meta-analysis of randomized controlled trials.","volume":"64","author":"Raval","year":"2020","journal-title":"J Clin Anesth"},{"key":"R25-20260430","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1213\/ANE.0000000000002670","article-title":"Consensus statement on perioperative use of neuromuscular monitoring.","volume":"127","author":"Naguib","year":"2018","journal-title":"Anesth Analg"},{"key":"R26-20260430","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/anae.15501","article-title":"Recommendations for standards of monitoring during anaesthesia and recovery 2021: Guideline from the Association of Anaesthetists.","volume":"76","author":"Klein","year":"2021","journal-title":"Anaesthesia"},{"key":"R27-20260430","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/EJA.0000000000001769","article-title":"Peri-operative management of neuromuscular blockade: A guideline from the European Society of Anaesthesiology and Intensive Care.","volume":"40","author":"Fuchs-Buder","year":"2023","journal-title":"Eur J Anaesthesiol"},{"key":"R28-20260430","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/ALN.0000000000004379","article-title":"2023 American Society of Anesthesiologists practice guidelines for monitoring and antagonism of neuromuscular blockade: A report by the American Society of Anesthesiologists task force on neuromuscular blockade.","volume":"138","author":"Thilen","year":"2023","journal-title":"Anesthesiology"},{"key":"R29-20260430","first-page":"101384","article-title":"Assessing pain in paralyzed critically ill patients receiving neuromuscular blocking agents: A monocenter prospective cohort.","volume":"43","author":"Voeltzel","year":"2024","journal-title":"Anaesth Crit Care Pain Med"},{"key":"R30-20260430","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.aucc.2023.07.038","article-title":"Nociception assessment with videopupillometry in deeply sedated intensive care patients: Discriminative and criterion validations.","volume":"37","author":"Favre","year":"2024","journal-title":"Aust Crit Care"},{"issue":"Suppl 1","key":"R31-20260430","doi-asserted-by":"crossref","first-page":"i95","DOI":"10.1093\/bja\/aev072","article-title":"Response of bispectral index to neuromuscular block in awake volunteers.","volume":"115","author":"Schuller","year":"2015","journal-title":"Br J Anaesth"},{"key":"R32-20260430","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4037\/ajcc2019917","article-title":"Bispectral index for titrating sedation in ARDS patients during neuromuscular blockade.","volume":"28","author":"Bass","year":"2019","journal-title":"Am J Crit Care"},{"key":"R33-20260430","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.ccm.0000474522.84637.6e","article-title":"Fixed-dose cisatracurium in acute respiratory distress syndrome sedation and analgesia.","volume":"43","author":"Bookstaver","year":"2015","journal-title":"Crit Care Med"},{"key":"R34-20260430","first-page":"e0371","article-title":"The implementation of protocol-based utilization of neuromuscular blocking agent using clinical variables in acute respiratory distress syndrome patients.","volume":"3","author":"Hadique","year":"2021","journal-title":"Crit Care Explor"},{"key":"R35-20260430","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","article-title":"Prone positioning in severe acute respiratory distress syndrome.","volume":"368","author":"Guerin","year":"2013","journal-title":"N Engl J Med"},{"key":"R36-20260430","doi-asserted-by":"crossref","first-page":"154469","DOI":"10.1016\/j.jcrc.2023.154469","article-title":"Neuromuscular blockade and oxygenation changes during prone positioning in COVID-19.","volume":"79","author":"Rollinson","year":"2024","journal-title":"J Crit Care"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000007002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:00:56Z","timestamp":1777579256000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000007002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000007002","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}